Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2
R. I. Connor, M. I. Sakharkar, C. G. Rappazzo, C. I. Kaku, N. C. Curtis, S. Shin, W. F. Wieland-Alter, J. A. Weiner, M. E. Ackerman, L. M. Walker, J. Lee, P. F. Wright
This study identifies infection-enhancing antibodies targeting the N-terminal domain of SARS-CoV-2 spike protein, which persist in convalescent patients and may be counteracted by viral mutations.
bioRxiv · Sep 19, 2023Immunology